A prospective study assessing the safety of anakinra and canakinumab in Patients with Cryopyrin Associated Periodic Syndromes
Latest Information Update: 23 Jun 2021
At a glance
- Drugs Anakinra (Primary) ; Canakinumab (Primary)
- Indications Cryopyrin-associated periodic syndromes
- Focus Adverse reactions
- 23 Jun 2021 New trial record
- 05 Jun 2021 Results presented at the 22nd Annual Congress of the European League Against Rheumatism